- Is there a role of nab-paclitaxel in the treatment of advanced non-small cell lung cancer? The data suggest yes
Liza C. Villaruz et al, 2016, European Journal of Cancer CrossRef - Weekly nab-Paclitaxel in Combination With Carboplatin as First-Line Therapy in Patients With Advanced Non–Small-Cell Lung Cancer: Analysis of Safety and Efficacy in Patients With Renal Impairment
Corey J. Langer et al, 2015, Clinical Lung Cancer CrossRef - In vivo synergistic anti-tumor effect of lumefantrine combined with pH responsive behavior of nano calcium phosphate based lipid nanoparticles on lung cancer
Vaidevi Sethuraman et al, 2021, European Journal of Pharmaceutical Sciences CrossRef - Impact des traitements utilisés en oncologie thoracique sur la fonction rénale
A.-C. Toffart et al, 2014, Revue des Maladies Respiratoires CrossRef - Toxicity of pemetrexed during renal impairment explained—Implications for safe treatment
René J. Boosman et al, 2021, International Journal of Cancer CrossRef - Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non–small cell lung cancer in Spain
Margarita Majem et al, 2022, Global & Regional Health Technology Assessment CrossRef